HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Valerie Speirs Selected Research

Male Breast Neoplasms (Male Breast Cancer)

10/2018Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer.
5/2017A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer.
1/2017Characterisation of male breast cancer: a descriptive biomarker study from a large patient series.
10/2016HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes.
11/2015Androgen receptor and antiandrogen therapy in male breast cancer.
5/2015Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis.
11/2014Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.
6/2012A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences.
9/2011Male breast carcinoma: increased awareness needed.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Valerie Speirs Research Topics

Disease

53Breast Neoplasms (Breast Cancer)
10/2022 - 06/2002
40Neoplasms (Cancer)
10/2022 - 01/2002
9Male Breast Neoplasms (Male Breast Cancer)
10/2018 - 09/2011
5Carcinoma (Carcinomatosis)
01/2022 - 06/2002
5Neoplasm Metastasis (Metastasis)
01/2019 - 08/2008
3Ductal Carcinoma
07/2016 - 06/2010
3Carcinogenesis
10/2011 - 06/2010
2Rare Diseases (Rare Disease)
08/2017 - 11/2014
2Noninfiltrating Intraductal Carcinoma (DCIS)
01/2015 - 12/2013
2Chromosomal Instability (Chromosome Stability)
11/2014 - 02/2012
1Prostatic Neoplasms (Prostate Cancer)
06/2022
1Papillary Carcinoma
01/2022
1Obesity
10/2016
1Fibroadenoma
12/2013
1Triple Negative Breast Neoplasms
12/2013
1Melanoma (Melanoma, Malignant)
03/2012
1Polyploidy
02/2012
1Disease Progression
09/2008
1Chromosome Aberrations (Chromosome Abnormalities)
09/2008

Drug/Important Bio-Agent (IBA)

14Biomarkers (Surrogate Marker)IBA
01/2021 - 06/2010
14Proteins (Proteins, Gene)FDA Link
01/2019 - 12/2003
13Estrogen ReceptorsIBA
10/2022 - 08/2003
11TamoxifenFDA LinkGeneric
01/2020 - 06/2002
9Hormones (Hormone)IBA
01/2022 - 04/2007
8Estrogen Receptor betaIBA
09/2010 - 12/2003
7Estrogen Receptor alphaIBA
10/2022 - 08/2006
7Protein Isoforms (Isoforms)IBA
12/2013 - 06/2002
5Indicators and Reagents (Reagents)IBA
10/2017 - 01/2008
5Androgen Receptors (Androgen Receptor)IBA
11/2015 - 08/2008
5Progesterone Receptors (Progesterone Receptor)IBA
10/2011 - 08/2006
4MicroRNAs (MicroRNA)IBA
10/2021 - 11/2013
3Biological ProductsIBA
01/2021 - 06/2012
3Androgen Antagonists (Antiandrogens)IBA
11/2015 - 11/2014
2Pharmaceutical PreparationsIBA
01/2017 - 10/2013
2Estrogen Receptor Modulators (Antiestrogen)IBA
11/2015 - 09/2008
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
05/2015 - 11/2014
2Aromatase InhibitorsIBA
05/2015 - 09/2011
2Cyproterone AcetateIBA
05/2015 - 11/2014
2Small Interfering RNA (siRNA)IBA
03/2014 - 08/2012
2AntibodiesIBA
01/2014 - 08/2008
2ParaffinIBA
03/2012 - 03/2008
2Formaldehyde (Formol)FDA Link
03/2012 - 03/2008
2Messenger RNA (mRNA)IBA
09/2011 - 06/2010
2DNA (Deoxyribonucleic Acid)IBA
09/2008 - 10/2003
1Poly(ADP-ribose) Polymerase InhibitorsIBA
06/2022
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
06/2022
1Dinoprostone (PGE2)FDA Link
01/2020
115-hydroxyprostaglandin dehydrogenaseIBA
01/2020
1Amino AcidsFDA Link
01/2019
1IsotopesIBA
01/2019
1teleocalcinIBA
10/2018
1Small Untranslated RNAIBA
01/2018
1Eukaryotic Initiation Factor-4EIBA
05/2017
1EverolimusFDA Link
05/2017
1Insulin-Like PeptidesIBA
05/2016
1Insulin-Like Growth Factor Binding ProteinsIBA
05/2016
1Insulin-Like Growth Factor Binding Protein 2IBA
05/2016
1Diphosphonates (Bisphosphonates)IBA
04/2016
1Zoledronic Acid (Zometa)FDA Link
04/2016
1CollagenIBA
01/2016
1IntegrinsIBA
11/2015
1AndrogensIBA
11/2015
1Aurora Kinase AIBA
11/2014
1SurvivinIBA
11/2014
1ATP dependent 26S protease (26S proteasome)IBA
03/2014
1SteroidsIBA
02/2014
1GemininIBA
01/2014
1Amine Oxidase (Copper-Containing)IBA
12/2013
1Pyridinolcarbamate (P23)IBA
12/2013
1trichostatin A (A 300)IBA
12/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2013
1Therapeutic UsesIBA
12/2013
1Histone Deacetylase InhibitorsIBA
12/2013
1Caveolin 1IBA
08/2012
1Phenobarbital (Luminal)FDA Link
06/2012
1Cell-Free Nucleic AcidsIBA
06/2012
1Paclitaxel (Taxol)FDA LinkGeneric
02/2012
1CeramidesIBA
02/2012
1CateninsIBA
10/2011
1ProlactinIBA
09/2011
1Fulvestrant (Faslodex)FDA Link
09/2011
1Forkhead Box Protein M1IBA
09/2011
1Serine (L-Serine)FDA Link
09/2010
15' Untranslated Regions (5' UTR)IBA
08/2010
1RNA (Ribonucleic Acid)IBA
08/2010
1OligonucleotidesIBA
09/2008
1Cyclin-Dependent Kinase Inhibitor p16IBA
09/2008
1Cyclin D1IBA
09/2008
1Anastrozole (Arimidex)FDA LinkGeneric
03/2008
1Epidermal Growth Factor (EGF)IBA
03/2008
1Cell Adhesion MoleculesIBA
01/2008
1Carcinoembryonic AntigenIBA
01/2008
1daidzeinIBA
08/2006
1CoumestrolIBA
08/2006
1Phytoestrogens (Phytoestrogen)IBA
08/2006

Therapy/Procedure

15Therapeutics
10/2021 - 01/2002
2Radiotherapy
01/2022 - 03/2014
2Drug Therapy (Chemotherapy)
10/2021 - 02/2012
2Lasers (Laser)
01/2015 - 01/2009
1Adjuvant Chemotherapy
02/2012